Insulin dependent Diabetics may now have ‘care freedom’

New Delhi: Religare Health Insurance, one of India’s leading health insurers unveiled a comprehensive health insurance plan – ‘care freedom’ that offers coverage to diabetics of all age groups and who are even dependent on insulin.

Diabetes is a lifestyle disorder in which patients experience high blood sugar level over a long period, it is either due to the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. In both the cases, a diabetic is dependent on the insulin intake and is at a higher risk of developing other life threatening complications, making diabetes an expensive ailment to put up with.

The launch is in line with the organization’s objective of ensuring persons diagnosed with such lifestyle diseases always have easy access to quality & specialised healthcare. Care Freedom does that by offering coverage without any pre-policy medical check-ups. Not just this, enrolment under the plan is applicable to individuals with multiple morbidities or health complications such as Hypertension, Lipid, Obesity (with BMI <= 37).

Furthermore, the plan covers pre-existing ailments after a short waiting period of just 2 years keeping in mind that most people of progressed age might already suffer from an existing health condition & might require support at the earliest.

Talking about the need for launching ‘Care Freedom’ a specifically designed product for diabetics, Mr. Anuj Gulati, MD and CEO, Religare Health Insurance said, “India is known to be the diabetes capital of the world with 49% of the global diabetes burden. Long term diabetes often lead to other complications such as heart diseases, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs leading to amputations. Association of these life threatening diseases with diabetes is the main reason why diabetics often find it difficult to get health insurance. Apart from diabetes, ‘Care Freedom’ also provides insurance to people suffering from depression, anxiety disorder, autism, hypertension etc.”

Care Freedom comes with a wide range of Sum Insured options from Rs. 3 lakhs to Rs 10 Lakhs and even offers a comprehensive health check-up that monitors certain vitals/parameters related to diabetes.

Related Posts

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’